Cargando…
Comparative study of efficacy and safety of cetirizine and bilastine in patients of chronic spontaneous urticaria: Open-label, randomized, parallel-group study
PURPOSE: Bilastine is a novel second-generation antihistaminic. Very few studies in Indian population have compared the safety and efficacy of bilastine with other second-generation antihistaminic like cetirizine. Hence, the present study was planned. MATERIALS AND METHODS: This was a randomized, op...
Autores principales: | Sinha, Vishakha V., Kalikar, Mrunalini Vinay, Mukhi, Jayesh Ishwardas, Giradkar, Akhil Bhagwan, Sontakke, Smita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679568/ https://www.ncbi.nlm.nih.gov/pubmed/38025284 http://dx.doi.org/10.4103/picr.picr_28_23 |
Ejemplares similares
-
Analysis of serious adverse events reports: Review by an Institutional Ethics Committee of a tertiary care teaching hospital
por: Dakhale, Ganesh Nathuji, et al.
Publicado: (2022) -
Analysis of clinical trial agreement and insurance policy submitted to the ethics committee of a tertiary care teaching institute in central India
por: Kalikar, Mrunalini V., et al.
Publicado: (2022) -
Bilastine for allergic rhinoconjunctivitis, urticaria
Publicado: (2022) -
Experience with bilastine in the management of urticaria: Original Real-world cases of Bilastine In Treatment (ORBIT) in Asia
por: Cheong, Wai Kwong, et al.
Publicado: (2022) -
Comparative evaluation of efficacy and tolerability of vilazodone, escitalopram, and amitriptyline in patients of major depressive disorder: A randomized, parallel, open-label clinical study
por: Kadam, Renuka L., et al.
Publicado: (2020)